Analysts predict that Healthways, Inc. (NASDAQ:TVTY) will post sales of $138.21 million for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Healthways’ earnings. The highest sales estimate is $138.90 million and the lowest is $137.35 million. Healthways reported sales of $125.05 million in the same quarter last year, which would suggest a positive year over year growth rate of 10.5%. The firm is expected to issue its next earnings report on Tuesday, November 7th.

On average, analysts expect that Healthways will report full-year sales of $138.21 million for the current financial year, with estimates ranging from $554.58 million to $557.50 million. For the next year, analysts expect that the firm will report sales of $607.86 million per share, with estimates ranging from $596.95 million to $622.16 million. Zacks Investment Research’s sales calculations are an average based on a survey of research firms that cover Healthways.

Healthways (NASDAQ:TVTY) last announced its earnings results on Thursday, July 27th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.38 by $0.03. Healthways had a return on equity of 29.81% and a net margin of 17.30%. The business had revenue of $138.90 million during the quarter, compared to analyst estimates of $138.15 million. Healthways’s quarterly revenue was up 11.1% on a year-over-year basis.

TVTY has been the subject of several recent research reports. BidaskClub raised shares of Healthways from a “buy” rating to a “strong-buy” rating in a research note on Friday, June 9th. ValuEngine raised shares of Healthways from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. UBS AG upped their price objective on shares of Healthways from $37.00 to $43.00 and gave the company a “buy” rating in a research note on Friday, June 23rd. Barrington Research upped their price objective on shares of Healthways from $35.00 to $44.00 and gave the company an “outperform” rating in a research note on Friday, July 28th. Finally, Cantor Fitzgerald upped their price objective on shares of Healthways from $34.00 to $42.00 and gave the company an “overweight” rating in a research note on Friday, June 9th. Two research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Healthways presently has an average rating of “Buy” and an average price target of $39.88.

Shares of Healthways (NASDAQ TVTY) opened at 38.35 on Tuesday. The firm has a market capitalization of $1.51 billion, a P/E ratio of 17.27 and a beta of 0.41. Healthways has a one year low of $19.25 and a one year high of $41.55. The firm’s 50-day moving average price is $37.97 and its 200-day moving average price is $34.68.

TRADEMARK VIOLATION WARNING: “Healthways, Inc. (TVTY) Expected to Announce Quarterly Sales of $138.21 Million” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/19/healthways-inc-tvty-expected-to-announce-quarterly-sales-of-138-21-million.html.

In related news, Director Conan Laughlin sold 1,750,000 shares of the stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $37.90, for a total value of $66,325,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Glenn Hargreaves sold 21,105 shares of the stock in a transaction dated Friday, August 4th. The stock was sold at an average price of $38.00, for a total transaction of $801,990.00. Following the completion of the transaction, the insider now directly owns 59,077 shares of the company’s stock, valued at $2,244,926. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,809,913 shares of company stock valued at $68,582,025. Insiders own 8.42% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in the stock. Flinton Capital Management LLC raised its stake in Healthways by 63.5% in the second quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock worth $139,000 after buying an additional 1,360 shares in the last quarter. Riverhead Capital Management LLC raised its stake in Healthways by 69.7% in the second quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock worth $142,000 after buying an additional 1,464 shares in the last quarter. Riggs Asset Managment Co. Inc. raised its stake in Healthways by 3.6% in the second quarter. Riggs Asset Managment Co. Inc. now owns 53,856 shares of the company’s stock worth $2,146,000 after buying an additional 1,867 shares in the last quarter. ClariVest Asset Management LLC bought a new position in Healthways in the first quarter worth about $141,000. Finally, US Bancorp DE bought a new position in Healthways in the first quarter worth about $145,000.

About Healthways

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Get a free copy of the Zacks research report on Healthways (TVTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Healthways (NASDAQ:TVTY)

Receive News & Stock Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related stocks with our FREE daily email newsletter.